-
Preventing spread of SARS coronavirus-2 in humans
worldpharmanews
March 06, 2020
Several coronaviruses circulate worldwide and constantly infect humans, which normally caused only mild respiratory disease.
-
Eli Lilly expects no coronavirus-related drug shortages
pharmaceutical-technology
March 05, 2020
Eli Lilly has announced that the company is not expecting coronavirus-related drug shortages, including all forms of insulin.
-
Coronavirus Rate in U.S. May Suddenly Jump, Warns Physicians for Civil Defense
PRNewswire
March 04, 2020
When the Centers for Disease Control and Prevention (CDC) assured President Trump that the risk of a coronavirus (COVID-19) outbreak in the U.S. was very low, only about 500 persons had been tested.
-
Europe on high alert as Coronavirus (Covid-19) spread intensifies
pharmaceutical-technology
March 04, 2020
European countries are on high alert as coronavirus (Covid-19) is spreading rapidly across the region.
-
Mateon launches antiviral programme focused on Covid-19
pharmaceutical-technology
March 04, 2020
Mateon Therapeutics has launched an antiviral response programme that will initially focus on Covid-19 disease caused by the novel coronavirus.
-
Exports of certain APIs, formulations put under restricted category
expresspharma
March 04, 2020
Exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12, have been put under restricted category amid the coronavirus outbreak in China, according to a government notification.
-
Pfizer identifies antiviral compounds with potential as coronavirus treatments
expresspharma
March 04, 2020
The company hopes to start testing them by the end of the year if any of the compounds are successful.
-
How Coronavirus Affects Travel to EU/EEA and UK as Non-EU Nationals Seek Plan B
prnasia
March 03, 2020
Travel to the Schengen area is likely to become difficult for those applying for a visa, according to EU's new Coronavirus response team.
-
Novavax starts animal testing of coronavirus vaccine candidates
pharmaceutical-technology
March 03, 2020
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models.
-
Sandoz to keep prices stable for potential coronavirus drugs
pharmaceutical-technology
March 03, 2020
Novartis subsidiary Sandoz has said that the company would keep prices stable for a basket of medicines, which may have the potential to treat patients infected by coronavirus.